Anlotinib combined with immune checkpoint inhibitors may benefit patients with extensive-stage small cell lung cancer treated ...

Panelists discuss how both amivantamab plus lazertinib and osimertinib-based regimens show good central nervous system (CNS) ...

Panelists discuss how the MARIPOSA study findings demonstrated significant progression-free survival and overall survival ...

Planning for adverse effects early on helps patients prepare for what lies ahead, says Michelle Kirschner, MSN, RN, ACNP, ...

In TP53 wild-type advanced or recurrent endometrial cancer, selinexor improved multiple time-to-event outcomes vs placebo.

Q&A: Prioritizing QOL Important to Treating HR+, HER2- Metastatic Breast Cancer ...

Formal communication could help ease the transition of care from specialized myeloma centers to community clinic, according ...

The NCCN has added taletrectinib to its recommendations for use in all lines of treatments for non–small cell lung cancer ...

Adjuvant aspirin did not reduce recurrence or improve survival in patients with CRC liver metastases, phase 3 data showed at ...

Oncology nurses can help patients understand this novel mechanism of action and its potential as a treatment option.

Subcutaneous daratumumab makes it easier for patients to find appointments that fit with their lifestyles and schedules, ...

The combination of relacorilant and nab-paclitaxel improved survival in platinum-resistant ovarian cancer following a break ...